{"title":"Wrestling with the RAS cancer drug pipeline","authors":"Asher Mullard","doi":"10.1038/d41573-025-00043-9","DOIUrl":null,"url":null,"abstract":"Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics. Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 4","pages":"242-243"},"PeriodicalIF":122.7000,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews. Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/d41573-025-00043-9","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics. Alice Shaw, Chief of Strategic Partnerships at Dana-Farber Cancer Institute, discusses the newly launched Center for RAS Therapeutics.
期刊介绍:
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena.
Each issue includes:
Highest-quality reviews and perspectives covering a broad scope.
News stories investigating the hottest topics in drug discovery.
Timely summaries of key primary research papers.
Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.